News

OREGA Biotech, the biotech company committed to the discovery of novel immuno-oncology targets for cancer immunotherapy, announced today the presentation of the preclinical data of its novel immune checkpoint  program at the upcoming SITC meeting to be held November 6...

As all the conditions precedent have been met, Baikowski® hereby confirms its acquisition of Mathym SAS, a company with which it commenced negotiations in July 2019. Complete press release Mathym

Alizé Pharma 3, a company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases, today announces that it has completed a €67 million Series A financing round. The oversubscribed Series A was led by LSP, and included Novo Ventures,...

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, and Evotec SE, a drug discovery and development company, today announce their partnership aimed at advancing Nosopharm’s lead candidate, NOSO-502, to the clinical stage, as...

C4Diagnostics has successfully reached several key milestones in the beginning of 2019: after its ISO13485 certification in January  2019, C4Diagnostics has secured its first product introduction on the market by entering into exclusive distribution agreements with...

The amount received from BPI will allow C4Diagnostics to speed up its development program for an automated AST platform based on its proprietary technology. This funding is received while C4Diagnostics is preparing the launch of its first product, C4LegioTM , for the...

Based in Lyon (France), Nukeygara startup raised 1M€ in funding with the financial support of Kreaxi (venture capital), three Business Angels and BPI France. These funds will allow to boost the business development of the 3D software Akeytsu, as well as support the...

Alizé Pharma 3, a company specialized in developing therapeutic peptides for the treatment of rare endocrine and metabolic diseases, today announces a key addition to its leadership team and the structuring of its product portfolio in line with its ambition to become...

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, today announces the appointment of Marie-Paule Richard and Gilles Alberici to its supervisory board. Alberici will be its new chairman. These new appointees will strengthen...

After a first round of $350k in January 2016, the French startup MailClark just announced that it has raised $900k in a second round led by Kreaxi, with participation from existing investor IT Translation as well as private and public funds. Founded in December 2014,...